Company Profile

Arterra BioScience S.p.A. specializes in the research and development of ingredients and active ingredients. Net sales break down by source of income as follows:
- sales of cosmetic raw materials (83.8%);
- sales of research services (16.2%).


Source: Cofisem - Last Update: 2024-04-02

Key Executives
Chairman and Chief Executive Officer Maria Gabriella Colucci
Chief Financial Officer Gualtiero Ioimo
Head of Investor Relations Alexandra Fellermeier


Source: Cofisem - Last Update: 2024-04-02

Key Figures
Millenium 2023 2022 2021 2020 2019
Net sales 3,304 3,563 3,825 2,822 2,709
Consumed purchases 425 678 370 534 494
Labour costs 1,476 1,391 1,228 1,127 1,025
Operating profit 1,059 1,601 1,248 1,201 940
Income tax 226 383 164 91 83
Net income 1,076 1,414 1,110 1,109 857
Net income (Group share) 1,076 1,414 1,110 1,109 857
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards US GAAP US GAAP US GAAP US GAAP US GAAP

Source: Cofisem - Last Update: 2024-04-02

Shareholder information
Maria Gabriella Colucci 27.9 %
Paolo Alfonso Colucci 7.52 %
Free float 50.88 %
Intercos S.p.A. 8.65 %
Zeus Capital Alternative – Best Opportunities SIF 5.05 %


Source: Cofisem - Last Update: 2024-04-02

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Arterra Bioscience


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.